Feryal Hajee, MD
Allergy · Little Silver, NJNPI 1841438447
Payments from drug & device makers
Across 371 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$2K
- AstraZeneca$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- GSK$803
- Pfizer$362
- Regeneron Healthcare Solutions, Inc.$290
- plus $2K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 16 | $2,489 |
| AstraZeneca | 83 | $2,403 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $1,527 |
| GSK | 70 | $803 |
| Pfizer | 19 | $362 |
| Regeneron Healthcare Solutions, Inc. | 18 | $290 |
| Grifols USA, LLC | 17 | $283 |
| CSL Behring | 16 | $260 |
| Amgen(2 entities) | 15 | $207 |
| Sanofi | 12 | $181 |
| Biocryst US Sales Co., LLC | 12 | $179 |
| Genentech USA, Inc. | 10 | $153 |
| Novartis | 7 | $117 |
| E.r. Squibb & Sons, L.L.C. | 1 | $114 |
| Cycle Pharmaceuticals Inc | 4 | $74 |
| Boehringer Ingelheim | 6 | $72 |
| Optinose US, Inc. | 4 | $58 |
| AbbVie | 4 | $54 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Alk-abello, Inc | 4 | $50 |
| Blueprint Medicines Corporation | 3 | $42 |
| Incyte Corporation | 3 | $42 |
| Octapharma USA, Inc. | 3 | $39 |
| Teva Pharmaceuticals USA, Inc. | 3 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $34 |
| Organon | 4 | $30 |
| Kaleo, Inc. | 2 | $26 |
| Shire North American Group Inc | 2 | $25 |
| Pulmonx Corporation | 1 | $22 |
| ADMA Biomanufacturing LLC | 1 | $18 |
| LEO Pharma Inc. | 1 | $14 |
| Bio Products Laboratory USA, Inc. | 1 | $14 |
How this compares
$10,079 in reported general payments places this provider in the 65th percentile of 35 allergy providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Little Silver
- John OppenheimerCedar Knolls$923K
- Jeffrey WeissRiverdale$836K
- Jay KashkinFair Lawn$486K
- Gregory TociMarlton$317K
- Jun YangTinton Falls$213K
- Shashank ShethVoorhees$127K
- Mathew VargheseNorth Bergen$93K
- Eugene GattiMarlton$43K
- Howard DruceSomerville$37K
- Donatella GraffinoCedar Knolls$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.